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Over the past few years, there has been a rise in interest in understanding the roles and functions of carbohydrates and carbohydrate conjugates at the chemical level. This has commonly become known as chemical glycobiology. 1 It is now well accepted that these derivatives play vital roles in a vast number of biological recognition events that range from cell-cell communication, fertilization, and cell growth and differentiation to pathological processes including cancer metastasis, inflammation, and microbial infections.
2 There are an immense number of glycoconjugate derivatives, and these are known to vary depending on stages of cell development, cell differentiation, and course of disease. It is becoming clear that the carbohydrate moieties of these glycoconjugates impact the architecture and function of underlying biomolecules and, as such, are also involved in important biological processes. Many examples have demonstrated that complex carbohydrates and their conjugates present on tumor cells possess unique structural features. Identification of these derivatives, followed by the development of chemically well-defined synthetic cancer vaccines is one such area of active research. 3 A major obstacle in the field of chemical glycobiology is our inability to access rapidly chemically well-defined complex carbohydrates, carbohydrate conjugates, carbohydrate mimics, as well as carbohydrate-based small-molecule chemical probes. 4 For example, synthetic derivatives of cellsurface glycoconjugates serve as attractive tools in understanding cell-surface-based recognition events and provide a good starting point in developing a new class of therapeutic agents. Small-molecule-derived inhibitors of carbohydrateprocessing enzymes (CPE) provide a means of controlling their biosynthetic pathways and offer new opportunities in carbohydrate-based therapeutic research.
Traditional synthesis of carbohydrates in any form is still a very challenging task, since there is no general method to produce complex carbohydrates as there is for proteins and nucleic acids. A typical synthesis consists of many protection and deprotection steps of multiple-hydroxyl groups, in addition to the fact that oligosaccharides are often branched rather than linear. 5 The linkages between monosaccharides can be either R or , and the formation of these linkages requires different conditions for different sugar building blocks. Solid-phase synthesis and combinatorial synthesis are emerging as excellent tools for producing large numbers of diverse or focused compounds. 6 The use of glycomimetics has also been developed as an alternative to carbohydrate synthesis. 7 It has been shown that the terminal sugars (two to four residues) and their conformation are critical for biological activities. It is with this in mind that we chose to develop an automated, combinatorial approach 8 to obtain artificial glycopeptides as small-molecule probes or mimics containing a dipeptide backbone with two sugar moieties attached.
Our quest has been to develop methodologies for generating novel carbohydrate-based small molecules for use as chemical probes for the study of carbohydrate-processing enzymes. We have developed a fully automated, combinatorial approach for rapidly accessing artificial glycopeptides as chemical probes. 9 It has been our hope that these highthroughput synthetic methods, which lead to artificial glycopeptides, will facilitate identification of useful chemical probes for chemical glycobiology and ultimately will provide inhibitors of carbohydrate-processing enzymes. In our design strategy, we have been interested in artificial glycopeptide derivatives that possess pertinent features of the underlying protein as well as the carbohydrate moiety, or glycoform of the glycoconjugates. This idea led to the development of carbohydrate diversity on a dipeptide/pseudo-peptide scaffold ( Figure 1 ). Models 1 and 2 demonstrate the flexibility of this approach. The carbohydrates were incorporated as Rand -linked C-glycosides, which are stable isosteres of native terminal sugars. 10 The versatility of this approach is reflected in the fact that a variety of sugars can be independently incorporated as peracetylated ethanal derivatives or ethanoic acid derivatives. Furthermore, these carbohydrate moieties may be present in the pyranose or furanose form. Figure 1 shows the four and five points of diversity that are utilized in this procedure. The building blocks (as carbon-linked sugar aldehydes and carbon-linked sugar acids) can be incorporated either at the N-terminal moiety or at the internal amide nitrogen of a short peptide/ pseudo-peptide scaffold. This can be done in a highly flexible and controlled manner. By use of this approach, libraries of artificial glycopeptides are readily synthesized for probing carbohydrate-protein interactions. The libraries display two, i.e., homogeneous and heterogeneous, copies of carbohydrates, while the dipeptide scaffold may contribute to secondary interactions with the biological target.
A retrosynthetic analysis reveals that the two libraries, models 1 and 2, can be obtained from a common precursor 3. Both libraries contain a reductively aminated sugar at the internal nitrogen 4, which is synthesized by coupling a sugar aldehyde to the free amine to form glycosylated amino acids. The next step is the coupling of a second amino acid to the secondary amine 3. The amine is then diversified by either reductive amination to give libraries of type 1, or sugar acid coupling leads to libraries of type 2. Each of the steps of this synthesis has been optimized, including the reductive amination step being optimized for each of the monosaccharides used.
Artificial glycopeptide libraries of models 1 and 2 have been successfully synthesized ( Figure 2 ) on TentaGel S RAM resin on a Multiple Organic Synthesizer (MOS). The success of the methodology was dependent on the optimization of the reductive amination reaction of the acetylated C-glycoside ethanal derivatives with the amino group of the anchored amino acid. After several attempts toward the synthesis of glycosyl amino derivative (see 3, Figure 1 ) on solid phase, the reductive amination product could be obtained in high yields (70-95%) by using only fewer equivalents of the glycoside derivatives. Now, in our hand, this reaction requires only 1.5 equiv (R-mannoside derivative), 2.0 equiv (Rglucoside derivatives, -galactoside derivatives) or 2.5 equiv ( -galactoside derivative) of the respective sugar derivatives, and the corresponding equivalents of sodium cyanoborohydride together with 0.5% glacial acetic acid. All the reagents were added in succession using trimethylorthoformate as the solvent and mixed for 4.5 h. This consistently gave high yields of the reductively aminated product without using the high concentrations of aldehyde (10 equiv) that is typically reported in the literature. The next challenging task was to optimize the coupling of the secondary amine having a glycoside derivative, with different amino acids. This coupling reaction turned out to be problematic for quite some time, and the products were formed in low yields. A significant amount of time has been spent to optimize this reaction in an automated synthesis method and to obtain the product with high yields (80-95%). The coupling of the resulting secondary amine to the next amino acid was accomplished with HATU reagent. The coupling of the acetylated ethanoic acid derivative of the respective sugar residue was also achieved with HATU reagent. Deacetylation of the sugar derivatives was achieved with a hydrazine hydrate/dimethylformamide mixture of pH 9-10 for 4.5 h. The time period as well as the pH was critical for on-bead deacetylation of the artificial glycopeptides. Cleavage of fully deprotected artifical glycopeptide from the resin was accomplished by mixing with trifluoroacetic acid for 2 h.
By use of the method discussed above, four 96-compound artificial glycopeptide libraries (Figures 3 and 4) have been synthesized in a fully automated manner. The artificial glycopetide library shown in Figure 3 contains two glycoside moieties (e.g., R-glucoside and R-mannoside). The synthesis of the first library (96 compounds) by automated solid-phase synthesis was obtained using model 1 as shown in Figure 1 . Two glycoside derivatives were incorporated onto the peptide template by a stepwise reductive amination reaction. In the second library synthesis (see Figure 3) , glycoside moieties were incorporated by the reductive amination reaction and the glycoside carboxyl acid coupling.
The compounds in artificial glycopeptide libraries were used as chemical probes in studying protein folding and trafficking, primarily of N-linked glycoproteins.
11 Work is in progress to test the ability of these derivatives to inhibit the reglucosylation of N-linked glycoprotein by a glucosederived carbohydrate-processing enzyme. 12 Reglucosylation of N-linked glycoprotein appears to be a critical step in N-glycoprotein biosynthesis and protein folding and trafficking pathways.
In a second study, the artificial glycopeptide libraries were tested in enzyme systems that convert a glucose moiety into rhamnose prior to incorporation of the rhamnose unit during the biosynthesis of the mycobacterium cell wall. 13 The inhibition of this step may play an important role in the development of novel, carbohydrate-derived therapies to combat mycobacterium tuberculosis cell-wall biosynthesis. Further, inhibition of this biosynthetic pathway may lead to the development of compounds with a specific action because this particular biotransformation does not occur in mammalian systems. To date, few artificial glycopeptide derivatives as potential glycoside-based inhibitors containing at least one negatively charged amino acid residue have been identified. Detailed biological studies are in progress.
14 Furthermore, the artificial glycopeptide derivatives from the libraries shown in Figures 3 and 4 (models 1 and 2) are being used as chemical probes or inhibitors for a study of the conversion of UDP-galactopyranose to UDP-galactofuranose via UDP-galactopyranose mutase enzyme.
14 The design and synthesis of inhibitors of this biosynthetic pathway is another interesting approach in the development of small-molecule- based agents that may have the potential of blocking the growth of the mycobacterium tuberculosis cell-wall biosynthesis.
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2.b. First Amino Acid Loading. TentaGel SRAM resin (200 mg, loading 0.24 mmol/g) was placed in each well of the 96-well block of the Advanced ChemTech 496 MOS. The resin was allowed to swell in DMF (2.0 mL) for 30 min and then was drained. The Fmoc group was removed with 20% piperidine/DMF (2.0 mL) for 40 min (2×). The resin was washed with DMF (2×), MeOH (2×), DMF (2×), MeOH (2×), DMF (2×). The C-terminal Fmoc amino acid (4 equiv) was coupled using HBTU (4 equiv) and DIPEA (8 equiv) for 25 h with one to two repeats based on MS analysis of representative samples. The resin was then washed with DMF (2×), MeOH (2×), DMF (2×), methanol (2×), and DMF (2×). The Fmoc group was removed as described, and the resin was washed as above using an additional wash with TMOf (2×) to prepare the resin for the next step.
2.c. Reductive Amination. The following reagents were added successively to the amino acid resin: protected C-linked sugar aldehyde (1.5-2.5 equiv) dissolved in TMOf, NaBH 3 CN (1.5-2.5 equiv dissolved in a minimum of dry MeOH and diluted to volume with TMOf), and glacial acetic acid in TMOf (0.5% final concentration calculated on the 2.0 mL volume of solvent in the well). The reagents were mixed for 4.5 h. The concentration of the sugar aldehyde must be optimized for the different sugars. For example, 2-(tetra-O-acetyl-D-mannopyranosyl)ethanal required 1.5 equiv, and the same 1.5 equiv was used for NaBH 3 CN. However, 2-(tetra-O-acetly-D-glucopyrannosyl)ethanal required 2.0 equiv, and the corresponding 2.0 equiv of NaBH 3 CN was used. After this reaction the resin was washed successively with TMOf (2×), DCM (2×), MeOH (2×), DCM (2×), MeOH (2×), and DMF (2×).
2.d. Amino Acid Coupling. Fmoc amino acid (4 equiv) was coupled with HATU (4 equiv) and DIPEA (8 equiv) for 40 h with one repeat, and samples were checked by ES-MS to ascertain if further couplings are required. After completion, the resin was washed successively with DMF (2×), MeOH (2×), DMF (2×), MeOH (2×), and DMF (2×). The Fmoc group was removed, and the resin was washed as described above. The next reaction was either a second reductive amination reaction (same procedure as the first reductive amination reaction as described above) or the coupling of the sugar acid.
2.e. Sugar Acid Coupling. The protected C-linked sugar derivative [2-(tetra-O-acetyl-D-manno-or glucopyranosyl)-ethanoic acid] (4 equiv) was coupled using HATU (4 equiv) and DIPEA (8 equiv) for 30 h with one repeat. Upon completion, the neoglycopeptide resin was washed with DMF (2×), MeOH (2×), DCM (2×), MeOH (2×), DCM (2×), MeOH (2×), and DMF (2×).
2.f. Deacetylation. The acetyl groups were then removed with H 2 NNH 2 ‚H 2 O/DMF (1:11 v/v), 2 mL for 4.5 h. After deacetylation, the artificial glycopeptide resin was washed with the following: DMF (2×), MeOH (2×), 30% acetic acid/MeOH, MeOH, 30% acetic acid/MeOH, MeOH.
2.g. Cleavage of Artificial Glycopeptide from the Resin. The resin was prepared for cleavage, dried for 1 h, and cleaved from the resin with TFA/TIPS/H 2 O (95:2.5:2.5 v/v/v) for 2 h.
2.h. Isolation of Artificial Glycopeptides. The cleaved neoglycopeptides were concentrated on the GeneVac and dried overnight under high vacuum. ES-MS was determined on the samples, and representative samples were purified by RP-HPLC on a Gilson HPLC equipped with a model 215 liquid handler.
